ImmunityBio, Inc. Securities Fraud Class Action Result of FDA Warning and 21% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Go back to ImmunityBio, Inc. Securities Fraud Class Action Result of FDA Warning and 21% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
(NASDAQ: IBRX) Delayed: 7.22 -0.14 (1.9%)
Previous Close $7.36    52 Week High
Open $7.49    52 Week Low
Day High $7.55    P/E N/A 
Day Low $7.17    EPS
Volume 9,796,937